UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 5, 2018
DS HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
______________
Florida |
| 001-35763 |
| 20-8380461 |
(State or Other Jurisdiction |
| (Commission |
| (I.R.S. Employer |
5379 Lyons Road, Coconut Creek, FL 33073
(Address of Principal Executive Office) (Zip Code)
(888) 404-7770
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
———————
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨ |
|
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On April 5, 2018 the Board of Directors of DS Healthcare Group, Inc. (the “Company”) received notice that Robert Bellaflores was resigning as Chief Financial Officer, Chief Administrative Officer, and as Director from the Board of Directors of the Company for personal reasons, effective immediately.
Also on April 5, 2018, the Board of Directors of the Company selected Myron Lewis, who currently is the Chairman of the Board of Directors, as its new Chief Accounting Officer.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DS HEALTHCARE GROUP, INC. |
| |
|
|
|
|
Date: April 26, 2018 | By: | /s/ Myron Lewis |
|
|
| Myron Lewis |
|
|
| Chairman of the Board |
|